| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 11/18/1999 | WO1999052562A3 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor |
| 11/18/1999 | WO1999050285A3 Production methods and uses of a retrovirus |
| 11/18/1999 | WO1999049855A3 Ipg antagonists for the treatment of conditions involving mast cells, basophils and eosinophils |
| 11/18/1999 | WO1999047153A3 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY rho GTPase FUNCTION INHIBITORS |
| 11/18/1999 | WO1999046284A9 Molecules that home to various selected organs or tissues |
| 11/18/1999 | WO1999046281A9 Novel polypeptides and nucleic acids encoding the same |
| 11/18/1999 | WO1999038981A3 Human protein kinase molecules |
| 11/18/1999 | WO1999027098A3 A-33 related antigens and their pharmacological uses |
| 11/18/1999 | DE19822036A1 Effervescent pharmaceutical composition with improved stability |
| 11/18/1999 | CA2332021A1 Diagnosis of predisposition to epilepsy and monitoring of antiepileptic treatment |
| 11/18/1999 | CA2331620A1 Use of neomycin for treating angiogenesis-related diseases |
| 11/18/1999 | CA2331350A1 Mucoadhesive compositions for administration of biologically active agents to animal tissue |
| 11/18/1999 | CA2331295A1 Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer |
| 11/18/1999 | CA2330000A1 Diagnosis and treatment of hepatic disorders |
| 11/18/1999 | CA2328521A1 Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto |
| 11/18/1999 | CA2328414A1 Methods for detecting and inhibiting angiogenesis |
| 11/18/1999 | CA2328406A1 Methods for regulating hematopoiesis using cpg-oligonucleotides |
| 11/18/1999 | CA2327354A1 Human apoptosis associated proteins |
| 11/18/1999 | CA2327351A1 Cell signaling proteins |
| 11/18/1999 | CA2324555A1 Pharmaceuticals for the imaging of angiogenic disorders |
| 11/17/1999 | EP0957172A2 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 11/17/1999 | EP0956867A1 Use of flavonoid glycosides, tanning agents and microorganisms for the therapy and prophylaxis of diabetes mellitus |
| 11/17/1999 | EP0956865A1 MEDICINES COMPRISING Rho KINASE INHIBITOR |
| 11/17/1999 | EP0956857A2 Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic |
| 11/17/1999 | EP0956506A1 Treatment and diagnosis of cancer |
| 11/17/1999 | EP0956350A1 Human chloride channel protein (hccp) |
| 11/17/1999 | EP0956342A1 Methods for identifying vasoprotective agents |
| 11/17/1999 | EP0956339A1 Recombinant vascular endothelial cell growth factor d (vegf-d) |
| 11/17/1999 | EP0956302A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes |
| 11/17/1999 | EP0956298A1 Snrnp sm proteins |
| 11/17/1999 | EP0956289A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 11/17/1999 | EP0956046A2 Cellular vaccines and immunotherapeutics and methods for their preparation |
| 11/17/1999 | EP0956044A1 Uses of a chemokine receptor for inhibiting hiv-1 infection |
| 11/17/1999 | EP0956040A1 Stimulation of host defense mechanisms against viral challenges |
| 11/17/1999 | EP0956036A1 Anti-fibrotic agent assay |
| 11/17/1999 | EP0956034A1 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin |
| 11/17/1999 | EP0956030A1 Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
| 11/17/1999 | EP0956022A1 Hormonal composition consisting of an oestrogen compound and of a progestational compound |
| 11/17/1999 | EP0956019A1 Novel therapeutic application of a thienycyclohexylamine derivative |
| 11/17/1999 | EP0956007A1 Chewing gum containing colloidal bismuth subcitrate |
| 11/17/1999 | EP0955995A1 Use of complexes for the preparation of compositions for the treatment of sensitive skin, preparation process and hypoallergenic compositions |
| 11/17/1999 | CN1235609A Immunostimulatory nucleic acid molecules |
| 11/17/1999 | CN1235556A Materials and methods relating to diagnosis and treatment of pre-eclampsia and diabetes |
| 11/17/1999 | CN1235554A Antifungal combination therapy |
| 11/17/1999 | CN1235512A Method for treating endothelial injury |
| 11/16/1999 | US5986058 Growth differentiation factor with amino acid sequences |
| 11/16/1999 | US5985938 Method for reducing oxalate |
| 11/16/1999 | US5985915 Cardiovascular disorders such as arrhythmia |
| 11/16/1999 | US5985891 Use of virginiamycin to control the passage of carbohydrates into the gastrointestinal tract and the fermentation of these carbohydrates therein, controlling the accumulation of acid in the digestive tract |
| 11/16/1999 | US5985890 Macrolide antibiotic having antitumor and antifungal activity |
| 11/16/1999 | US5985880 Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
| 11/16/1999 | US5985877 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
| 11/16/1999 | US5985866 Use of serotonin antagonists for treating fibromyalgia |
| 11/16/1999 | US5985854 Prodrugs with enhanced penetration into cells |
| 11/16/1999 | US5985851 Use of hyaluronic acid or its derivatives in peritoneal dialysis and formulations thereof |
| 11/16/1999 | US5985850 Comprising a therapeutically effective amount of an agent to treat a disease or condition involving underperfused tissue and pathological tissue in humans and a form of hyaluronic acid as transport agent |
| 11/16/1999 | US5985843 Pharmaceutical composition containing sucralfate |
| 11/16/1999 | US5985640 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
| 11/16/1999 | US5985604 Polynucleotide |
| 11/16/1999 | US5985600 Nucleic acid encoding delta opioid receptor |
| 11/16/1999 | US5985592 Uses for pentoxifylline or functional derivatives/metabolites thereof |
| 11/16/1999 | US5985589 Dna sequences |
| 11/16/1999 | US5985583 Hybridization; measurement signal transduction |
| 11/16/1999 | US5985305 Sustained delivery of an active agent using an implantable system |
| 11/16/1999 | US5985248 Preparing dry powders having hydrophobic and hydrophilic components |
| 11/16/1999 | US5985214 Systems and methods for rapidly identifying useful chemicals in liquid samples |
| 11/16/1999 | US5984887 Photopheresis treatment of leukocytes |
| 11/14/1999 | CA2270022A1 Combination of dofetilide and a calcium channel blocker |
| 11/13/1999 | CA2248987A1 Novel compounds |
| 11/11/1999 | WO1999057320A1 Antisense modulation of cd40 expression |
| 11/11/1999 | WO1999057312A1 New method for the selection of clones of an expression library involving rearraying |
| 11/11/1999 | WO1999057303A1 A method for diagnosing and treating chronic pelvic pain syndrome |
| 11/11/1999 | WO1999057288A1 Endothelin-converting-enzyme like protein |
| 11/11/1999 | WO1999057274A1 Human protease associated proteins |
| 11/11/1999 | WO1999057270A2 Human receptor molecules |
| 11/11/1999 | WO1999057144A2 Human transcriptional regulator molecules |
| 11/11/1999 | WO1999057138A1 Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppresssant and methods of use thereof |
| 11/11/1999 | WO1999057131A1 Method of treating bladder and lower urinary tract syndromes |
| 11/11/1999 | WO1999056783A1 Hydrogel for the therapeutic treatment of aneurysms |
| 11/11/1999 | WO1999056778A1 The cytokine family member, 2-19 |
| 11/11/1999 | WO1999056769A2 Inhibition of helicobacter pylori proliferation |
| 11/11/1999 | WO1999056768A1 Methods for treating diabetes by inhibiting gdf-8 |
| 11/11/1999 | WO1999056763A1 Use of neglected target tissue antigens in modulation of immune responses |
| 11/11/1999 | WO1999056755A1 Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides |
| 11/11/1999 | WO1999056753A1 Hematopoietic stimulation |
| 11/11/1999 | WO1999056749A1 IMPROVED METHOD FOR ERADICATION OF $i(HELICOBACTER PYLORI) |
| 11/11/1999 | WO1999056745A1 New use |
| 11/11/1999 | WO1999056726A1 Use of pharmaceutical compositions capable of being gelled in periodontology |
| 11/11/1999 | WO1999056725A1 Pharmaceutical compositions capable of being gelled |
| 11/11/1999 | WO1999049316A3 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 11/11/1999 | WO1999047677A3 Polypeptides homologous to vegf and bmp1 |
| 11/11/1999 | WO1999043354A3 Method for treating painful conditions of the anal region and compositions therefor |
| 11/11/1999 | WO1999042821A3 Treating cancer |
| 11/11/1999 | WO1999041402A3 Targeting of genetic vaccine vectors |
| 11/11/1999 | WO1999029863A9 Human interferon-epsilon: a type i interferon |
| 11/11/1999 | CA2331844A1 A method for diagnosing and treating chronic pelvic pain syndrome |
| 11/11/1999 | CA2331122A1 Hematopoietic stimulation |
| 11/11/1999 | CA2331070A1 New use |
| 11/11/1999 | CA2329986A1 New method for the selection of clones of an expression library involving rearraying |
| 11/11/1999 | CA2328602A1 Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides |